Grants Search Results
Grants Search
Interested in applying for a St. Baldrick’s Foundation grant? Learn more about the grant application process.
Funding Type: Consortium Research Grant
Institution Location: Barretos, Brazil
Institution: Hospital de Cancer de Barretos
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
Funding Type: Consortium Research Grant
Institution Location: Sao Paolo, Brazil
Institution: Centro Infantil Boldrini
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
Funding Type: Infrastructure Grant
Institution Location: Rio de Janiero, Brazil
Institution: Instituto Nacional de Câncer
This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.
Funding Type: Infrastructure Grant
Institution Location: São Paulo, Brazil
Institution: Hospital Santa Marcelina
This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.
Funding Type: Infrastructure Grant
Institution Location: São Paulo, Brazil
Institution: A.C. Camargo
This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.
Funding Type: Infrastructure Grant
Institution Location: Porto Alegre, Rio Grande do Su
Institution: Hospital de Clínicas de Porto Alegre
This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.
Funding Type: Infrastructure Grant
Institution Location: Sao Paulo, Sao Paulo
Institution: Instituto De Oncologia Pediatrica
This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.
Funding Type: Beneficiary Outside the U.S.
Institution Location: Rio de Janeiro,
Institution: Fundacao do Cancer
Through this partnership with the Fundacao do Cancer, proceeds from St. Baldrick's head-shaving events in Brazil support life-saving childhood cancer research in Brazil.
Funding Type: Cooperative Research Grant (COG)
Institution Location: Campinas, Sao Paulo
Institution: Boldrini Childrens Center
This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 through 2004, St. Baldrick's funds benefitted the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.
Funding Type: Cooperative Research Grant (COG)
Institution Location: Sao Paulo, Sao Paulo
Institution: Instituto De Oncologia Pediatrica
This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 through 2004, St. Baldrick's funds benefitted the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.